TABLE 1.
No. | Gender | Age | CML phase | Imatinib-resistant | WBC | Hb | Plt | Cytogenetics | Folder of HO-1 expression in patients/donors | Folder of NHE-1 expression in patients/donors |
---|---|---|---|---|---|---|---|---|---|---|
years | g/liter | g/dl | g/liter | |||||||
1 | M | 58 | CP | No | 4.11 | 147 | 109 | t (9:22) | 1.05 ± 0.06 | 1.98 ± 0.05 |
2 | M | 23 | CP | No | 3.67 | 137 | 375 | t (9:22) | 2.54 ± 0.03 | 1.76 ± 0.06 |
3 | M | 35 | CP | No | 4.02 | 143 | 154 | t (9:22) | 0.98 ± 0.07 | 2.34 ± 0.08 |
4 | M | 49 | CP | No | 1.57 | 72 | 13 | t (9:22) | 1.02 ± 0.04 | 0.98 ± 0.09 |
5 | M | 29 | CP | No | 3.83 | 145 | 485 | t (9:22) | 1.03 ± 0.06 | 0.79 ± 0.11 |
6 | F | 34 | AP | No | 33.93 | 54 | 355 | t (9:22) | 0.46 ± 0.05 | 1.32 ± 0.08 |
7 | M | 26 | AP | Yes | 123.4 | 90 | 359 | t (9:22) | 4.12 ± 0.21 | 2.46 ± 0.24 |
8 | M | 22 | CP | No | 209.8 | 83 | 629 | t (9:22) | 5.02 ± 0.18 | 3.06 ± 0.15 |
9 | F | 39 | CP | No | 12.8 | 111 | 235 | t (9:22) | 1.11 ± 0.08 | 1.00 ± 0.04 |
10 | M | 22 | BP | Yes | 24.45 | 102 | 987 | t (9:22) | 1.98 ± 0.11 | 2.57 ± 0.12 |
11 | M | 38 | CP | No | 5.36 | 126 | 162 | t (9:22) | 0.84 ± 0.04 | 1.75 ± 0.06 |
12 | M | 46 | CP | No | 4.7 | 135 | 133 | t (9:22) | 0.89 ± 0.07 | 2.31 ± 0.07 |
13 | M | 22 | BP | Yes | 16.67 | 53 | 24 | t (9:22) | 1.73 ± 0.04 | 1.54 ± 0.08 |
14 | M | 45 | AP | Yes | 45.89 | 96 | 18 | t (9:22) | 1.98 ± 0.06 | 1.78 ± 0.06 |
15 | F | 55 | AP | No | 9.54 | 49 | 27 | t (9:22) | 1.76 ± 0.09 | 2.98 ± 0.07 |
16 | F | 77 | CP | No | 20.14 | 126 | 150 | t (9:22) | 2.40 ± 0.13 | 1.99 ± 0.13 |
17 | F | 34 | CP | No | 7.66 | 102 | 18 | t (9:22) | 1.31 ± 0.08 | 2.01 ± 0.07 |
18 | F | 45 | AP | Yes | 61.52 | 80 | 307 | t (9:22) | 2.03 ± 0.13 | 2.16 ± 0.09 |
19 | M | 46 | BP | Yes | 164 | 39 | 14 | t (9:22) | 3.87 ± 0.23 | 2.56 ± 0.17 |
20 | F | 45 | AP | No | 32.19 | 77 | 78 | t (9:22) | 1.89 ± 0.14 | 1.58 ± 0.08 |
21 | F | 50 | BP | Yes | 34.63 | 60 | 3 | t (9:22) | 1.26 ± 0.09 | 1.74 ± 0.15 |
22 | M | 28 | BP | No | 31.63 | 53 | 286 | t (9:22) | 1.18 ± 0.08 | 1.02 ± 0.06 |
23 | M | 43 | CP | No | 14.46 | 90 | 262 | t (9:22) | 2.78 ± 0.07 | 1.05 ± 0.03 |
24 | M | 54 | AP | Yes | 105.41 | 137 | 133 | t (9:22) | 0.93 ± 0.06 | 1.19 ± 0.06 |
25 | M | 21 | BP | No | 6.35 | 90 | 358 | t (9:22) | 1.79 ± 0.04 | 1.31 ± 0.13 |
26 | F | 36 | AP | Yes | 68.89 | 115 | 428 | t (9:22) | 3.50 ± 0.23 | 2.34 ± 0.21 |
27 | M | 40 | AP | Yes | 240.65 | 84 | 476 | t (9:22) | 5.30 ± 0.17 | 3.54 ± 0.32 |
28 | M | 31 | CP | No | 6.32 | 90 | 86 | t (9:22) | 1.63 ± 0.05 | 1.08 ± 0.07 |
29 | M | 85 | CP | No | 0.43 | 53 | 12 | t (9:22) | 2.01 ± 0.04 | 0.89 ± 0.06 |
30 | F | 38 | CP | No | 3.98 | 109 | 151 | t (9:22) | 2.54 ± 0.12 | 2.01 ± 0.09 |
31 | F | 36 | BP | No | 7.24 | 114 | 337 | t (9:22) | 1.04 ± 0.07 | 0.99 ± 0.08 |
32 | M | 26 | CP | No | 7.67 | 137 | 439 | t (9:22) | 1.23 ± 0.11 | 1.12 ± 0.06 |
33 | F | 60 | CP | No | 8.59 | 136 | 542 | t (9:22) | 0.95 ± 0.08 | 0.93 ± 0.07 |
34 | F | 38 | BP | Yes | 12.85 | 100 | 279 | t (9:22) | 1.24 ± 0.09 | 1.13 ± 0.07 |
35 | F | 26 | CP | No | 2.61 | 108 | 140 | t (9:22) | 0.68 ± 0.09 | 0.94 ± 0.08 |